We are live on !
Find out more
Profund Advisors Portfolio holdings
AUM
$3.48B
Turnover
14.37%
1-Year Est. Return
66.96%
ProFund Advisors manages the ProFunds mutual funds, which include index funds across sectors, bonds, currencies and crypto, as well as leveraged and inverse funds. The ProFunds brand dates from 1997, and its affiliate ProShares began offering leveraged and inverse ETFs in 2006. The Bitcoin ProFund tracks bitcoin futures rather than holding bitcoin itself.
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+66.96%
3 Year Est. Return
+258.11%
5 Year Est. Return
+342.15%
10 Year Est. Return
+1,333.1%
AUM
$3.48B
AUM Growth
-$153M
(-4.2%)
Cap. Flow
-$155M
Cap. Flow % of AUM
Cap. Flow %
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
41.36%
Holding
1,225
New
50
Increased
319
Reduced
729
Closed
126
Avg Time Held
6.2
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$37.8M |
| 2 |
Alumis Inc
ALMS
|
+$2.98M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$1.65M |
| 4 |
Reddit
RDDT
|
+$1.57M |
| 5 |
Septerna Inc
SEPN
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$46.8M |
| 2 |
Broadcom
AVGO
|
+$15.2M |
| 3 |
Micron Technology
MU
|
+$13.3M |
| 4 |
Apple
AAPL
|
+$12.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 54.2% |
| 2 | Healthcare | 10.88% |
| 3 | Communication Services | 8.15% |
| 4 | Consumer Discretionary | 7.38% |
| 5 | Industrials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Qnity Electronics Inc
Q
$24.7B
| $1.62M | 0.05% |
12,857
-1,671
| -12% | -$219K |
2025 Q4
3 quarters
|
|
252
BHP
BHP
$202B
| $1.61M | 0.05% |
19,017
+582
| +3% | +$50.7K |
2022 Q4
15 quarters
|
|
253
Innoviva
INVA
$1.35B
| $1.61M | 0.05% |
76,047
+61,248
| +414% | +$1.3M |
2024 Q4
7 quarters
|
|
254
Veeva Systems
VEEV
$48.8B
| $1.6M | 0.05% |
5,622
-542
| -9% | -$127K |
2014 Q4
47 quarters
|
|
255
Baidu
BIDU
$26.6B
| $1.6M | 0.05% |
18,445
+934
| +5% | +$94.5K |
2013 Q2
53 quarters
|
|
256
Dominion Energy
D
$59.5B
| $1.6M | 0.05% |
26,372
-1,164
| -4% | -$78.2K |
2013 Q2
53 quarters
|
|
257
Corning
GLW
$98.3B
| $1.59M | 0.05% |
10,317
-1,017
| -9% | -$162K |
2022 Q4
15 quarters
|
|
258
Prologis
PLD
$122B
| $1.58M | 0.05% |
12,175
+2,764
| +29% | +$388K |
2013 Q2
53 quarters
|
|
259
HSBC
HSBC
$306B
| $1.58M | 0.05% |
15,890
+1,709
| +12% | +$175K |
2013 Q2
53 quarters
|
|
260
Trip.com Group
TCOM
$27.4B
| $1.56M | 0.04% |
39,845
+1,618
| +4% | +$69.7K |
2013 Q2
53 quarters
|
|
261
Tango Therapeutics
TNGX
$4.32B
| $1.55M | 0.04% |
62,319
+20,430
| +49% | +$532K |
2025 Q3
4 quarters
|
|
262
Prestige Consumer Healthcare
PBH
$2.19B
| $1.55M | 0.04% |
33,690
+26,305
| +356% | +$1.31M |
2013 Q2
53 quarters
|
|
263
Omeros
OMER
$1.27B
| $1.53M | 0.04% |
80,616
+54,297
| +206% | +$822K |
2025 Q4
3 quarters
|
|
264
Harmony Biosciences
HRMY
$1.98B
| $1.53M | 0.04% |
39,094
+29,599
| +312% | +$1.14M |
2022 Q4
15 quarters
|
|
265
Maze Therapeutics
MAZE
$1.88B
| $1.53M | 0.04% |
56,281
+45,256
| +410% | +$1.26M |
2026 Q2
1 quarter
|
|
266
Sempra
SRE
$52B
| $1.53M | 0.04% |
19,607
-860
| -4% | -$74.4K |
2013 Q2
53 quarters
|
|
267
Tarsus Pharmaceuticals
TARS
$3.96B
| $1.52M | 0.04% |
19,378
+14,385
| +288% | +$1000K |
2024 Q1
10 quarters
|
|
268
Pan American Silver
PAAS
$15.5B
| $1.51M | 0.04% |
33,112
-457
| -1% | -$21.8K |
2013 Q2
53 quarters
|
|
269
Danaher
DHR
$164B
| $1.5M | 0.04% |
6,793
-222
| -3% | -$45.6K |
2013 Q2
53 quarters
|
|
|
270
Septerna Inc
SEPN
$2.03B
| $1.5M | 0.04% |
+38,262
| New | +$1.45M |
2026 Q3
0 quarters
|
|
271
Edgewise Therapeutics
EWTX
$5.03B
| $1.49M | 0.04% |
36,798
+27,634
| +302% | +$1.17M |
2024 Q2
9 quarters
|
|
272
Charles Schwab
SCHW
$160B
| $1.48M | 0.04% |
15,141
+1,441
| +11% | +$152K |
2013 Q2
53 quarters
|
|
273
Royalty Pharma
RPRX
$30.9B
| $1.48M | 0.04% |
25,344
+20,696
| +445% | +$1.22M |
2020 Q3
24 quarters
|
|
274
MBX Biosciences
MBX
$2.78B
| $1.47M | 0.04% |
25,021
+16,209
| +184% | +$1.01M |
2025 Q4
3 quarters
|
|
275
Ecolab
ECL
$86.7B
| $1.46M | 0.04% |
5,332
-2,589
| -33% | -$719K |
2013 Q2
53 quarters
|
|
Similar funds
TC
SHIM
Profund Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Profund Advisors held 1,225 positions worth $3.48B, down 4.2% from $3.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Profund Advisors withdrew a net $155M in Q3 2026, closing 126 positions and reducing 729 holdings. Its most notable exit was Electronic Arts, an estimated $5.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 54% of assets, down from 56% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Profund Advisors opened a new position in SpaceX worth $41.3M.
- Profund Advisors's largest Q3 2026 buy was SpaceX: 273,453 shares worth $41.3M.
- Profund Advisors added most to Alumis Inc in Q3 2026, an estimated $2.98M increase.
- Profund Advisors's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $46.8M.
- Profund Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $5.2M.
- Profund Advisors's ten largest holdings make up 41% of its $3.48B portfolio in Q3 2026.
- Profund Advisors opened 50 new positions and closed 126 in Q3 2026.
- Profund Advisors's portfolio value fell 4.2% quarter-over-quarter to $3.48B.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.